Mutations in IDH1 and, less frequently, IDH2 now define a secondary glioblastoma (low-grade gliomas that eventually underwent a malignant transformation) [3,6], whereas the IDH1 wild-type is considered to be a primary glioblastoma that arose as a higher-grade tumour. This evidence concerns the gene IDH1 and central nervous system cancer.